Definium Therapeutics Inc.(DFTX:US)
Market Cap$4.261B
Key Metrics
Price$32.10
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$353.79M
EBITDA (TTM)-$214.75M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$655.27M
Total Assets$1.113B
Net Assets$918.68M
Total Debt$36.47M
Key Metrics
Price$32.10
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$353.79M
EBITDA (TTM)-$214.75M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$655.27M
Total Assets$1.113B
Net Assets$918.68M
Total Debt$36.47M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - |
| $75.08M | $59.22M | $47.58M | $45.67M | $40.9M | $32.16M | $32.46M | |
| Research and Development | $48.67M | $41.48M | $33.52M | $30.98M | $29.81M | $23.36M | $21.76M |
| Selling, General, and Administrative | $26.41M | $17.74M | $14.06M | $14.69M | $11.09M | $8.8M | $10.7M |
| Other Operating Expenses | - | - | - | - | - | - | - |
Operating Income | -$75.08M | -$59.22M | -$47.58M | -$45.67M | -$40.9M | -$32.16M | -$32.46M |
| -$83.91M | -$17.88M | -$2.86M | -$21.6M | -$1.84M | $8.81M | -$2.28M | |
| Non-Operating Interest Income | $3.59M | $3.46M | $3.49M | $2.26M | $2.77M | $2.43M | $3.28M |
| Non-Operating Interest Expense | $1.23M | $1.25M | $1.27M | $1.27M | $2.34M | $602K | $656K |
| Other Income/Expense | -$86.26M | -$20.09M | -$5.08M | -$22.58M | -$2.28M | $6.98M | -$4.9M |
Income Before Tax | -$158.99M | -$77.1M | -$50.44M | -$67.27M | -$42.74M | -$23.35M | -$34.74M |
Income Tax | - | - | - | - | - | - | - |
Net Income | -$158.99M | -$77.1M | -$50.44M | -$67.27M | -$42.74M | -$23.35M | -$34.74M |
Minority Interests | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - |
Net Income to Common | -$158.99M | -$77.1M | -$50.44M | -$67.27M | -$42.74M | -$23.35M | -$34.74M |
Shares Outstanding (Basic) | 110.68M | 108.79M | - | 85.89M | 85.35M | 85.07M | 83.93M |
Shares Outstanding (Diluted) | 110.68M | 108.79M | - | 85.89M | 85.35M | 87.09M | 83.93M |
EPS (Basic) | -$1.44 | -$0.71 | - | -$0.78 | -$0.50 | -$0.27 | -$0.41 |
EPS (Diluted) | -$1.44 | -$0.71 | - | -$0.78 | -$0.50 | -$0.35 | -$0.41 |
EBIT | -$157.75M | -$75.85M | -$49.17M | -$65.99M | -$40.41M | -$22.75M | -$34.09M |
EBITDA | -$71.49M | -$55.76M | -$44.09M | -$43.41M | -$38.13M | -$29.73M | -$29.18M |